Hip Displacement in Cerebral Palsy: The Role of Surveillance

IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context.     

Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density

Background Intravitreal triamcinolone acetonide (TA) has been widely used as a therapeutic method for many ocular diseases, but a consensus on an appropriate safe therapeutic window of dosage for intravitreal injection, and whether vehicle of TA should be reduced or eliminated, has not yet been reached. The aim of this article is to investigate these issues.Methods Forty New Zealand white rabbits were divided into four experimental groups and one control group. Four or 25 mg TA, with vehicle either reduced or not, was injected into the vitreous cavity of rabbits in experimental groups. Rabbits in the control group received 0.2 ml intravitreal sterile saline solution. Intraocular pressures (IOP) were measured by a Tonopen tonometer. Values of lens density were measured by a Pentacam system. Soluble protein, total antioxidation capacity, reduced glutathione (GSH), glutathion peroxidase (GSH-px), and superoxide dismutase (SOD) in lens were measured by specific kits. ERG and pathological examinations, including light and electron microscopy of the retina, were also performed.Results Elevation of IOP was noted in all experimental groups after intravitreal TA (P<0.01, paired t-test). Significant increase of lens density was noticed at 1 week after intravitreal TA in the 25 mg vehicle-containing group (P<0.0001, paired t-test). Significant loss of GSH-px activity was noticed at the end of the study (P<0.05, paired t-test), while SOD activity increased (P<0.05, paired t-test). Amplitudes of ERG waves declined significantly in vehicle-containing groups (P<0.01, paired t-test) at the end of the study. Pathological examination showed obvious retinal toxicity in vehicle-containing groups.Conclusions Vehicle of TA should be eliminated or reduced before intravitreal injection to avoid potential retinal toxicity and transient increase in lens density.Presented at Chinese Academy of Fundus Disease Meeting, April, 2005.This study was supported by the 985 Fund of Peking University, Beijing.The authors have no financial interest in any instruments or drugs mentioned in this study.     

晶体玻璃体视网膜联合手术治疗复杂性视网膜脱离

目的探讨玻璃体视网膜手术（ｖｉｔｒｅｒｅｔｉｎａｌｓｕｒｇｅｒｙ，ＶＲ术）联合晶体切除／超声粉碎的效果。方法对８１例（８１只眼）应用晶体玻璃体视网膜联合手术（ｌｅｎｔｉｃｕｌａｒ－ｖｉｔｒｅｏｒｅｔｉｎａｌｓｕｒｇｅｒｙ，ＬＶＲ术）治疗的复杂性视网膜脱离进行回顾性分析。结果解剖性成功者６４只眼（７９．０１％），功能性成功者４５只眼（５５．５６％）；手术成功率显著降低的原因是前部增殖性玻璃体视网膜病变（ｐｒｏｌｉｆｅｒａｔｉｖｅｖｉｔｒｅｏ－ｒｅｔｉｎｏｐａｔｈｙ，ＰＶＲ）（成功率４２．８６％，Ｐ＜０．０１）和术中／术后眼内出血（成功率５８．８２％，Ｐ＜０．０２５）。结论ＬＶＲ术是治疗复杂性视网膜脱离的主要方法；显著影响手术预后的因素是前部ＰＶＲ和术中／术后眼内出血。     

经皮穿刺L_5S_1椎间盘后1/3的应用解剖

在28例成人标本上经骼骨钻孔和非髂骨钻孔法做经皮穿刺L_5S_1椎间盘后1/3,分层解剖观测,探针依次经过皮肤,肌肉,纤维环至髓核;并观察针与临近最下腰动脉脊支。股神经,闭孔神经和腰骶干的解剖关系。实验表明:遵循操作规则,使用锥形扩张器,用上述两种方法穿刺L_5S_1椎间盘后1/3都是安全,可行的。     

颞颌关节不可复性盘前移位上腔造影与关节腔冲洗的临床应用

目的 通过TMJ上腔造影，结合关节腔冲洗、注药及术后下颌磨牙区牙合垫治疗不可复性盘前移位。方法 根据病史结合临床症状选取38例患者，其中单纯性不可复性盘前移位患者15例，合并滑膜炎表现23例。按常规进行关节上腔造影术后拍摄数字化TMJ开闭口断层片、开口度检查，部分患者使用生理盐水进行关节腔冲洗。冲洗后根据病情，关节腔内注入强地松龙或透明质酸钠，注药后再次测量开口度。结果 不可复关节盘移位开口度及髁突侧向运动度明显增加。合并滑膜炎者疼痛症状减轻。结论 TMJ关节上腔造影结合关节腔冲洗注药及He垫治疗，可明显增加开口度、髁突运动度。减轻关节疼痛。因此，是一种治疗早期不可复性盘前移位的有效方法。     

197例腰椎间盘膨出和脱出的CT分型

根据１９７例腰椎间盘病变的ＣＴ影像以及手术所见，提出腰椎间盘膨出分为均匀型、不均匀型、局限型；腰椎间盘脱出分为中央型、旁侧型、孔外型、Ｓｃｈｍｏｒｌ结节型。除Ｓｃｈｍｏｒｌ结节型外，上述椎间盘脱出可继续分为隆起型、破裂型、游离型等三个亚型。还讨论了分型的必要性、病理基础与临床关系以及鉴别诊断。     

经皮激光椎间盘减压术治疗颈性眩晕的临床研究

目的探讨经皮激光椎间盘减压术治疗颈性眩晕的疗效及机制。方法对31例颈性眩晕患者36个突出间盘行经皮激光椎间盘减压术，观察术后3个月以上的疗效。结果28例术后眩晕立即消除(90％)，明显改善者2例(7％)，无效者1例(3％)，无神经损害、感染等并发症发生。结论导致颈性眩晕的主要原因是颈椎间盘突出、颈椎失稳，激惹交感神经诱发椎动脉痉挛。钩突关节肥大并非是主要致病因素。经皮激光椎间盘减压术使椎间盘内压骤然降低，加之局部直接热疗，从而可消除椎动脉痉挛，对治疗颈性眩晕有明显疗效。     

外伤性胸椎间盘突出症的早期诊断与手术治疗

[目的]探讨外伤性胸椎间盘突出症的临床表现、早期诊断及手术治疗效果。[方法]2000年6月-2005年6月共收治外伤性胸椎间盘突出症患者11例，其中男8例，女3例，年龄15-38岁，平均23．96岁。诊断时间距外伤时间最短的为2d，最长的8个月，平均4．1个月。早期明确诊断后行经关节突入路胸椎间盘摘除术。[结果]11例患者获得1、1-3．8年术后随访，平均随访2．6年。根据Otani’s等分级方法进行疗效评价：优7例，良3例，可1例，差0例，失败0例。手术优良率为90．91％。[结论]外伤性胸椎间盘突出较少见，无典型临床表现，本症的早期诊断及早期手术治疗是远期优良疗效的保证。     

腰椎间盘突出症早期手术并发症的回顾性分析

腰椎间盘突出是腰腿痛的主要原因,因患病率高,手术开展较为普及,关于其手术后并发症的相关报导也逐渐增多。为了进一步了解这些并发症的发生原因,我们将1993年2月至2004年12月手术治疗腰椎间盘突出症768例中所发生的74例早期并发症进行回顾性分析,针对手术的危险因素提出相应的     

腰椎间盘突出症治疗方法与肌电图变化的相关性研究

腰椎间盘突出症(lumbar disc herniation，LDH)是导致腰腿痛的主要病因，本研究对具有典型临床症状、相应体征及MR或CT等影像学资料确诊的LDH，采用规范化非手术治疗，经规范化保守治疗无效者选用手术治疗，治疗前后均行肌电图(elec-tromyograptly，EMG)检查，旨在探讨肌电图变化与治